Meiji Pharma USA Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants (NCT07422207) | Meiji Pharma USA Inc. | 2026-03-23 |
| Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis (NCT05268016) | Meiji Pharma USA Inc. | 2022-03-24 |
Track Meiji Pharma USA Inc. automatically
Every clearance here is in the API, with alerts when new ones post.